Archive for December 2025
Reflections from the American Epilepsy Society Meeting 2025
Earlier this month, KCNQ2 Cure Alliance members attended the American Epilepsy Society (AES) meeting in Atlanta, Georgia. Our goal was to connect with scientists, clinicians, and industry partners to learn…
Read MoreQ2 Quick Note #06: KCNQ2 Variants and Their Effects on Patient-Derived Neurons
Researchers compared different pathogenic KCNQ2 variants to see how they affected the way neurons grew, the genes they expressed, and how they functioned. What It’s About Stem cells donated by…
Read MorePromising Results from EMBOLD Study: What this Means for the KCNQ2 Community
KCNQ2 Cure Alliance attended the American Epilepsy Society (AES) meeting this week. One of the biggest pieces of news shared was positive results from a clinical trial testing a new…
Read MoreQ2 Quick Note #05: Gene Effects Only Partly Explain KCNQ2-DEE Developmental Challenges
A new study found that for people with KCNQ2–DEE, the severity of their variant’s effect on Kv7.2 channel function was only modestly correlated with the severity of their developmental symptoms.…
Read MoreQ2 Quick Note #04: Review Article Highlights Mouse Models of KCNQ2-DEE
A new review article (an article that summarizes other articles) was published, providing an in-depth overview of mouse models with genetically altered sodium and potassium channels. What It’s About This…
Read More